Atai Beckley Inc. (ATAI)
$7.38+0.00%Close
BUYBULL · day 23
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2.7B
- Avg volume
- 10.5M
- Beta
- 1.55
- P/E (TTM)
- -2.54
- Short % float
- 9.88%
- Days to cover
- 1.0
- SI change
- -47.5%
- 1W
- +1.93%
- 1M
- +2.79%
- 3M
- +70.83%
- YTD
- +90.70%
- vs SPY 1W
- +3.12%
- vs SPY 1M
- -0.54%
- vs SPY 3M
- +68.44%
- vs SPY YTD
- +78.94%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CCCCBUYC4 Therapeutics, Inc.RECOVERYQ -0$4.10+2.50%
- NNVCSELLNanoViricides, Inc.CRISISQ 6$1.27-4.51%
- OSRHSELLOSR Holdings, Inc.CRISISQ -21$0.25-10.71%
- POMBUYPOMDOCTOR LtdRECOVERYQ -36$0.97+2.11%
- KRROBUYKorro Bio, Inc.RECOVERYQ -15$13.07-0.83%
- ATRABUYAtara Biotherapeutics, Inc.RECOVERYQ -7$9.46-2.47%
- MRMDBUYMariMed Inc.RECOVERYQ 14$0.08-11.11%
- RBOTSELLVicarious Surgical Inc.CRISISQ -35$0.03-25.00%
- ATHESELLAlterity Therapeutics LimitedRECOVERYQ 3$4.57-2.14%
- WVESELLWave Life Sciences Ltd.CRISISQ 9$5.12-3.21%
- SGMOSELLSangamo Therapeutics, Inc.CRISISQ 4$0.07+16.67%
- BGMSSELLBio Green Med Solution, Inc.BEARQ -36$0.87+0.00%
Industry peers
FMP comparable companies · ranked by market cap
- DNTHBUYDianthus Therapeutics, Inc.$6.2BBULLQ 4$111.10-0.93%
- AMLXBUYAmylyx Pharmaceuticals, Inc.$4.3BRECOVERYQ 10$38.66-1.32%
- ELVNBUYEnliven Therapeutics, Inc.$4.3BBULLQ 15$59.82+2.22%
- RLAYBUYRelay Therapeutics, Inc.$4.3BBULLQ 4$19.44+1.65%
- NKTRBUYNektar Therapeutics$2.1BRECOVERYQ 13$74.02-0.45%
- SNDXSELLSyndax Pharmaceuticals, Inc.$1.7BRECOVERYQ 18$19.65-0.41%
- INBXBUYInhibrx Biosciences Inc.$1.5BRECOVERYQ 33$103.63+1.26%
- ORICBUYORIC Pharmaceuticals, Inc.$1.5BBULLQ 4$14.20-5.21%
- IMTXSELLImmatics N.V.$1.2BCRISISQ 8$8.93-2.69%
- SANABUYSana Biotechnology, Inc.$1.1BRECOVERYQ -4$3.91-3.32%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 4
- GROWTH
- 19
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-211.9%
REV YoY-
ROE-353.2%
EPS YoY-
ROA-252.3%
GROSS86
OP-3274
NET-14938
[VALUATION]
P/E TTM-2.54
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B15.10
P/FCF-
EV/EBITDA-3.78
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E2.43
ALTMAN Z-
CURR RATIO8.58
ND/EBITDA-
BETA1.55
